American Portfolios Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.21K Hold
450
﹤0.01% 3094
2022
Q2
$1.86K Hold
450
﹤0.01% 3151
2022
Q1
$2.62K Hold
450
﹤0.01% 3161
2021
Q4
$3.38K Hold
450
﹤0.01% 3026
2021
Q3
$4.05K Hold
450
﹤0.01% 2937
2021
Q2
$5.39K Hold
450
﹤0.01% 2781
2021
Q1
$5.64K Buy
450
+100
+29% +$1.35K ﹤0.01% 2646
2020
Q4
$5.46K Sell
350
-275
-44% -$3.22K ﹤0.01% 2372
2020
Q3
$5.91K Hold
625
﹤0.01% 2206
2020
Q2
$5.6K Hold
625
﹤0.01% 2192
2020
Q1
$3.98K Hold
625
﹤0.01% 2189
2019
Q4
$5.23K Hold
625
﹤0.01% 2262
2019
Q3
$5.66K Sell
625
-300
-32% -$3.37K ﹤0.01% 2154
2019
Q2
$9.96K Hold
925
﹤0.01% 1903
2019
Q1
$8.82K Buy
925
+100
+12% +$1.02K ﹤0.01% 1877
2018
Q4
$9.47K Sell
825
-100
-11% -$1.24K ﹤0.01% 1654
2018
Q3
$15.7K Hold
925
﹤0.01% 1578
2018
Q2
$13.1K Buy
925
+725
+363% +$12K ﹤0.01% 1619
2018
Q1
$3.8K Buy
200
+100
+100% +$2.14K ﹤0.01% 1966
2017
Q4
$1.64K Buy
+100
New +$1.49K ﹤0.01% 2082

Other funds holding SGMO

American Portfolios Advisors's SGMO Position: Q3 2022 in Review

American Portfolios Advisors held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2022 at 450 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #3094.

American Portfolios Advisors first reported a position in SGMO in Q4 2017 and has held it in 20 quarters since. The position peaked at $15.7K in Q3 2018. 197 funds tracked by Wall St. Rank hold SGMO as of Q3 2022.

  • American Portfolios Advisors held 450 shares of SANGAMO THERAPEUTICS INC worth $2.21K as of Q3 2022.
  • American Portfolios Advisors left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2022.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3094 holding.
  • American Portfolios Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's SANGAMO THERAPEUTICS INC position peaked at $15.7K in Q3 2018.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.